(Q35165380)

6 August 2017

1 reference

title

Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure (English)

1 reference

6 August 2017

0 references

chronic heart failure

1 reference

Noritoshi Nagaya

1

1 reference

6 August 2017

Kenji Kangawa

series ordinal

2

1 reference

6 August 2017

language of work or name

1 reference

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

114

1 reference

6 August 2017

issue

2-3

1 reference

6 August 2017

page(s)

71-77

1 reference

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Stimulation of cardiac protein synthesis by insulin-like growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

THE PATHOGENESIS OF CARDIAC CACHEXIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Tumour necrosis factor alpha in severe congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Growth hormone secretagogues: focus on the growth hormone-releasing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A nonpeptidyl growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A receptor in pituitary and hypothalamus that functions in growth hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Physiology of isolated gastric endocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin Strongly Stimulates Growth Hormone Release in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Post-prandial decrease of circulating human ghrelin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Increased fasting plasma ghrelin levels in patients with bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Vasodilatory effect of ghrelin, an endogenous peptide from the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Idiopathic Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Growth Hormone Improves Cardiac Performance in Experimental Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Treatment With Growth Hormone Enhances Contractile Reserve and Intracellular Calcium Transients in Myocytes From Rats With Postinfarction Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

A placebo-controlled study of growth hormone in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2803%2900117-4

7 January 2021

10.1016/S0167-0115(03)00117-4

Identifiers

DOI

1 reference

6 August 2017

1 reference